Search

everythinglearnresearchcommunity

for

Search:↓

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

The sebaceous gland has more roles than just producing sebum and contributing to acne, and new research could lead to better skin disease treatments.

The document concludes that minoxidil and finasteride are proven for hair growth, herbal remedies show promise, but more research is needed to confirm their effectiveness.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Finasteride is a safe, effective treatment for hirsutism with fewer side effects.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

Light can turn on hair growth cells through a nerve path starting in the eyes.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Testosterone and dihydrotestosterone affect hair growth, and new techniques like the folliculogram help study it, but fully understanding hair growth is still complex.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Vitamin D3 analogs can promote hair growth in mice genetically prone to hair loss.

Asian hair is generally straight and thick, with unique disorders and properties, and more research is needed to understand it fully.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.